» Articles » PMID: 15485635

Human T Regulatory Cells Can Use the Perforin Pathway to Cause Autologous Target Cell Death

Overview
Journal Immunity
Publisher Cell Press
Date 2004 Oct 16
PMID 15485635
Citations 372
Authors
Affiliations
Soon will be listed here.
Abstract

Cytotoxic T lymphocytes and natural killer cells use the perforin/granzyme pathway to kill virally infected cells and tumor cells. Mutations in genes important for this pathway are associated with several human diseases. CD4(+) T regulatory (Treg) cells have emerged as important in the control of immunopathological processes. We have previously shown that human adaptive Treg cells preferentially express granzyme B and can kill allogeneic target cells in a perforin-dependent manner. Here, we demonstrate that activated human CD4(+)CD25(+) natural Treg cells express granzyme A but very little granzyme B. Furthermore, both Treg subtypes display perforin-dependent cytotoxicity against autologous target cells, including activated CD4(+) and CD8(+) T cells, CD14(+) monocytes, and both immature and mature dendritic cells. This cytotoxicity is dependent on CD18 adhesive interactions but is independent of Fas/FasL. Our findings suggest that the perforin/granzyme pathway is one of the mechanisms that Treg cells can use to control immune responses.

Citing Articles

T Cell Resistance: On the Mechanisms of T Cell Non-activation.

Beckers D, Jainarayanan A, Dustin M, Capera J Immune Netw. 2025; 24(6):e42.

PMID: 39801736 PMC: 11711127. DOI: 10.4110/in.2024.24.e42.


Advancing immunosuppression in liver transplantation: the role of regulatory T cells in immune modulation and graft tolerance.

Han J, Park S Clin Transplant Res. 2024; 38(4):257-272.

PMID: 39696994 PMC: 11732766. DOI: 10.4285/ctr.24.0059.


High-affinity chimeric antigen receptor signaling induces an inflammatory program in human regulatory T cells.

Cochrane R, Robino R, Granger B, Allen E, Vaena S, Romeo M Mol Ther Methods Clin Dev. 2024; 32(4):101385.

PMID: 39687729 PMC: 11647616. DOI: 10.1016/j.omtm.2024.101385.


CD137-expressing regulatory T cells in cancer and autoimmune diseases.

Lee K, Mei Y, Liu H, Schwarz H Mol Ther. 2024; 33(1):51-70.

PMID: 39668561 PMC: 11764688. DOI: 10.1016/j.ymthe.2024.12.010.


The 'T paradox' in inflammatory arthritis.

Schnell J, Briviesca R, Kim T, Charbonnier L, Henderson L, van Wijk F Nat Rev Rheumatol. 2024; 21(1):9-21.

PMID: 39653758 DOI: 10.1038/s41584-024-01190-w.